Child with Rare, Genetic, Neurological Disease Receives Diagnosis, With C. elegans’ Help
A team of researchers from around the world has solved the mystery of a child with a rare genetic illness that did not fit any known disease.
Related Articles
Why won’t this expert’s clients sign onto AI projects for more than
Andy Sajous, a leader in digital transformation, explains. He discusses the tradeoffs of building versus buying artificial intelligence tools and describes some crucial actions CIOs…
Fossils tell tale of devastating mass extinction when Mediterranean dried up
Hundred of species perished 6 million years ago as sea became salt desert
Elusive Cures
A neuroscientist’s bold proposal for tackling one of the greatest challenges of our time—brain and mental illnesses
Understanding the sense of self through robotics
Robots can be used to study and understand the sense of self as a fundamental phenomenon of human nature.
Improve cyberdefense through collaborative decisions
Eric Liederman, chief executive officer of CyberSolutionsMD, says developing an “all of us approach” on what to do and how to do it can help…
Understanding healthcare delivery and cybersecurity
Dr. Eric Lieberman, CEO of CybersolutionsMD, discusses advising care organizations on ensuring collaborative decision-making in cybersecurity for patient safety – and the government’s role in…
CRISPR Nobelists surrender their own European patents
Nature Biotechnology – A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPR–Cas9 technology.
Vietnam OKs Korean predictive sepsis AI
This marks AITRICS’s first foray into Southeast Asia, with applications for regulatory clearance in Indonesia and Malaysia underway.
Online Event
The spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD) ranges from simple lipid accumulation in the human liver, to steatohepatitis with inflammation, fibrosis, cirrhosis, and…
ASHG Attendees Share Meeting Expectations, Thoughts on U.S. Election Impact on Science
We asked several researchers to share their perspectives on ASHG 2024 and the potential impact of the U.S. election results on science and biotech.